Edit
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

With the emergence and long-term Impact of COVID-19, the Global Plasma Fractionation Market is to reach USD 58.42 Billion by 2030

Bizwit Research & Consulting LLP’s Recent Analysis on Global Plasma Fractionation Market is poised to raise up to USD 58.42 Billion by 2030. Plasma fractionation is a process used to separate different components of blood plasma, such as proteins and other bioactive substances. Blood plasma is the liquid component of blood that remains after red blood cells, white blood cells, and platelets have been removed.

Plasma fractionation plays a vital role in the production of various therapeutic products, including immunoglobulins, albumin, clotting factors, and other specialized plasma-derived products. These products are used for treating a wide range of medical conditions, such as immune deficiencies, hemophilia, clotting disorders, and certain neurological diseases. The Plasma Fractionation market is expanding because of factors such as growing incidences of immunodeficiency disorders, surge in demand for plasma derived medicinal products and growing geriatric population.

In addition, adoption of Plasma Proteins in immunology & neurology procedures and increasing R&D projects involving plasma treatments. The successful launch of this product may provide patients with an alternative option is creating lucrative growth to the market. However, the high cost of plasma fractionation and emergence of recombinant therapies as an alternative to plasm

Geographically, the global Plasma Fractionation market has been segmented into North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa (MEA). North America dominated the market in 2022 owing to the dominance of branded products and the region’s increasing disease prevalence. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

The global Plasma Fractionation market is highly competitive owing to the presence of several key manufacturers such as Grifols S.A., CSL Limited, Takeda Pharmaceutical Company Limited, Octapharma AG, Kedrion S.p.A, LFB S.A., Biotest AG, and others.

For further analysis on this or to request a sample copy of this report, please click the link mentioned below:

Global Plasma Fractionation Market Size study & Forecast, by Product ( Albumin, Immunoglobulins, Coagulation Factors, Protease Inhibitors, Others), by Method (Centrifugation, Depth Filtration, Chromatography, Others)by Application (Neurology, Hematology, Oncology, Immunology, Pulmonology, Others), by End User(Hospitals & Clinics, Clinical Research, Others) and Regional Analysis, 2023-2030

Key findings of the study suggest:

  • Global Plasma Fractionation market is anticipated to grow with a healthy growth rate of more than 8.3% over the forecast period 2023-2030.
  • In the Product segment, Immunoglobulins emerged as the leading market segment in 2022.
  • North America is anticipated to drive regional growth owing to the increasing prevalence of target diseases.
  • Asia Pacific is expected to grow at a high CAGR followed by North America during 2023-2030.

Bizwit Research & Consulting has considered the following segments for the study:

By Product:

  • Albumin
  • Immunoglobulins
  • Coagulation Factors
  • Protease Inhibitors
  • Others

By Method:

  • Centrifugation
  • Depth Filtration
  • Chromatography
  • Others

By Application:

  • Neurology
  • Hematology
  • Oncology
  • Immunology
  • Pulmonology
  • Others

By End User:

  • Hospitals & Clinics
  • Clinical Research
  • Others

Regional Outlook

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • ROE
  • Asia Pacific
    • China
    • India
    • Japan
    • Korea
    • Australia
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa

To get a sample of this report or to purchase a copy of the study, you can directly contact us at: sales@bizwitresearch.com

About Us

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. The company has a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. Bizwit incorporate big data, expert analysis, and huge industry database to deliver client focused business consulting reports. Our analysts perform unbiased measurement and assessment of market opportunities to comprehend detailed market forecast. Our team of key opinion leaders evaluates the market size, growth prospects, end-use, applications, value & supply chain and top vendors in the industry to help the clients to take conversant business decisions without any vague assumptions.

Contact US

Global Business Development

Phone : +1 209 498-3066

Email: Sales@bizwitresearch.com

Website: www.bizwitresearch.com

Leave a Reply

Your email address will not be published. Required fields are marked *